Discover the promising new BK channel opener, SPG601, now entering clinical trials for Fragile X syndrome. Learn about its potential to restore synaptic function and address core symptoms.
Read moreBriault, Sylvain
Sylvain Briault, PhD, Team Leader at CNRS Orleans, researches neurodevelopmental disorders and received a FRAXA Research Foundation grant in 2012 to study certain drug effects on Fragile X mice.
Sensory Hypersensibility in Fragile X Syndrome and BK Channel Openers
![Sensory Hypersensibility in Fragile X Syndrome and BK Channel Openers FRAXA Research Team. From left to right: Sandrine Lefeuvre (PhD, Pharmacologist), Sylvain Briault (MD, PhD, head of the team), Julie Maublanc (PhD student, Pharmacologist), Olivier Perche (PhD, hospital engineer), Béatrice Laudier (MD, PhD student), Betty Hébert (PhD student), Arnaud Menuet (PhD, assistant professor) and Jacques Pichon (Professor, Dr es Science).](https://www.fraxa.org/wp-content/uploads/2013/07/The-FRAXA-team-CNRS-INEM7355-e1428512177825-556x300.jpg)
With $366,100 in grants from FRAXA Research Foundation, these investigators at the University of Orleans studied sensory abnormalities in Fragile X mice and test the ability of a class of drugs, BK channel openers, to rescue these abnormalities.
Read more